LCN2 and neoplasm: GO analysis also revealed activation of the tumor necrosis factor (TNF) and Janus kinase (JAK)-STAT signaling pathways in PC9-BM cells (Supplementary Fig. 5a) and in tumor cells with high LCN2 expression in clinical BM patient samples (Fig. 3a).